The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Interferon-α and Autoimmune Thyroid Disease
Abstract
Interferon-alpha (IFN alpha) is the main therapeutic agent in patients infected with the hepatitis C virus (HCV). It is rather safe, but is known to induce the production of autoantibodies and can lead to the occurrence of autoimmune disease. This minireview focuses on the induction of autoimmune thyroid disease (AITD) in HCV-infected patients treated with IFN alpha. Females carry a higher risk to develop AITD upon IFN alpha treatment, with a relative risk of 4.4 (95% confidence interval 3.2-5.9). The presence of thyroid peroxidase antibodies before therapy has a relative risk for AITD of 3.9 (95% confidence interval 1.9-8.1). IFN alpha-associated AITD can consist of autoimmune primary hypothyroidism, Graves' hyperthyroidism, and destructive thyroiditis, with hypothyroidism being the most common side effect. The clear association between AITD and IFN alpha use suggests that high endogenous IFN alpha levels may also be associated with naturally occurring AITD. High endogenous IFN alpha levels are seen in patients infected with certain viruses. It is concluded that IFN alpha is one of the environmental factors capable of triggering the onset of AITD in genetically susceptible individuals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a review of published cases from eight series, 69% of 49 patients with IFN-a-associated thyrotoxicosis for whom an etiology was identified were found to have GD, based on either positive TRAb titers or requirement for a prolonged course of ATDs ( 640).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [640]
Citations
Cites
Lauer, G. M., & Walker, B. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107053450107 · Cited by 3,033
An overview of the immune system
Parkin, J., & Cohen, B. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04904-7 · Cited by 1,593
Interferons α and β as Immune Regulators—A New Look
Biron, C. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00154-6 · Cited by 666
Autoimmune Thyroid Disease: Further Developments in Our Understanding*
Weetman, A. P., & McGregor, A. M. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-6-788 · Cited by 656
Fattovich, G., Giustina, G., Favarato, S., & Ruol, A. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80184-x · Cited by 483
Side effects of high-dose interferon therapy for chronic hepatitis C
Okanoue, T., Sakamoto, S., Itoh, Y., Minami, M., Yasui, K., Sakamoto, M., Nishioji, K., Katagishi, T., Nakagawa, Y., Tada, H., et al. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80113-9 · Cited by 456
Molecular Pathways in Virus-Induced Cytokine Production
Mogensen, T. H., & Paludan, S. R. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.1.131-150.2001 · Cited by 418
Side effects of α interferon in chronic hepatitis C
Dusheiko, G. M. (1997) · Hepatology · doi:10.1002/hep.510260720 · Cited by 394
Autoimmune thyroid disease: further developments in our understanding
Weetman, A. P. (1994) · Endocrine Reviews · doi:10.1210/er.15.6.788 · Cited by 216
Marazuela, M., Garcı́a-Buey, L., González‐Fernández, B., García‐Monzón, C., Arranz, A., Borque, M. J., & Moreno‐Otero, R. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.751768.x · Cited by 210
Cited by
Sorted by citations
Ross, D. S., Burch, H. B., Cooper, D. S., Greenlee, M. C., Laurberg, P., Maia, A. L., Rivkees, S. A., Samuels, M., Sosa, J. A., Stan, M. N., et al. (2016) · Thyroid® · doi:10.1089/thy.2016.0229 · Cited by 2,938
“In a review of published cases from eight series, 69% of 49 patients with IFN-a–associated thyrotoxicosis for whom an etiology was identified were found to have GD, based on either positive TRAb titers or requirement for a prolonged course of ATDs (640).”
BackgroundSelf-citationBahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., Rivkees, S. A., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.3.456 · Cited by 1,098
Self-citationThe American Thyroid Association and American Association of Clinical Endocrinologists Taskforce on Hyperthyroidism and Other Causes of Thyrotoxicosis, Bahn, R. S., Burch, H. B., Cooper, D. S., Garber, J. R., Greenlee, M. C., Klein, I., Laurberg, P., McDougall, I. R., Montori, V. M., et al. (2011) · Thyroid · doi:10.1089/thy.2010.0417 · Cited by 898
Self-citationCross-regulation of TNF and IFN-α in autoimmune diseases
Palucka, K., Blanck, J.-P., Bennett, L. B., Pascual, V., & Banchereau, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408506102 · Cited by 518
The environment and autoimmune thyroid diseases
Prummel, M. F., Strieder, T. G. A., & Wiersinga, W. M. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500605 · Cited by 298
Self-citationBreaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity.
Mclachlan, S., & Rapoport, B. (2014) · Endocrine reviews · doi:10.1210/er.2013-1055 · Cited by 230
Extrahepatic manifestations of chronic HCV infection.
Galossi, A., Guarisco, R., Bellis, L., & Puoti, C. (2007) · PubMed · Cited by 195
The clinical and physiological spectrum of interferon‐alpha induced thyroiditis
Mandac, J. C., Chaudhry, S., Sherman, K. E., & Tomer, Y. (2006) · Hepatology · doi:10.1002/hep.21146 · Cited by 193
Side Effects of Cytokines Approved for Therapy
Baldo, B. A. (2014) · Drug Safety · doi:10.1007/s40264-014-0226-z · Cited by 195
Thyroid peroxidase autoantibodies in euthyroid subjects
Prummel, M. F., & Wiersinga, W. M. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.11.003 · Cited by 182
Self-citationPharmacology and therapeutic potential of interferons
George, P. M., Badiger, R., Alazawi, W., Foster, G. R., & Mitchell, J. A. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.03.006 · Cited by 182
The interplay between thyroid and liver: implications for clinical practice
Piantanida, E., Ippolito, S., Gallo, D., Masiello, E., Premoli, P., Cusini, C., Rosetti, S., Sabatino, J., Segato, S., Trimarchi, F., et al. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01208-6 · Cited by 183
Type I Interferons in the Pathogenesis and Treatment of Autoimmune Diseases
Jiang, J., Zhao, M., Chang, C. C.-C., Wu, H., & Lu, Q. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08798-2 · Cited by 166
Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C
Sulkowski, M., Cooper, C., Hunyady, B., Jia, J., Ogurtsov, P. P., Peck‐Radosavljevic, M., Shiffman, M. L., Yurdaydın, C., & Dalgård, O. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.21 · Cited by 149
Interferon Alpha Treatment and Thyroid Dysfunction
Tomer, Y., Blackard, J. T., & Akeno, N. (2007) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2007.07.001 · Cited by 142
Thyroid Disorders in Chronic Hepatitis C Virus Infection
Antonelli, A., Ferri, C., Fallahi, P., Ferrari, S. M., Ghinoi, A., Rotondi, M., & Ferrannini, E. (2006) · Thyroid · doi:10.1089/thy.2006.16.563 · Cited by 136
Interferon-α-Related Thyroid Disease: Pathophysiological, Epidemiological, and Clinical Aspects
Carella, C., Mazziotti, G., Amato, G., Braverman, L., & Roti, E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0627 · Cited by 132
Coco, G., Dal Pra, C., Presotto, F., Albergoni, M. P., Canova, C., Pedini, B., Zanchetta, R., Chen, S., Furmaniak, J., Rees Smith, B., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0860 · Cited by 127
Low Serum Vitamin D Is Associated with Anti-Thyroid Peroxidase Antibody in Autoimmune Thyroiditis
Shin, D. Y., Kim, K. J., Kim, D., Hwang, S., & Lee, E. J. (2014) · Yonsei Medical Journal · doi:10.3349/ymj.2014.55.2.476 · Cited by 122
Hypothyroidism in the Elderly: Pathophysiology, Diagnosis and Treatment
Laurberg, P., Andersen, S., Pedersen, I. B., & Carl, A. B. (2005) · Drugs & Aging · doi:10.2165/00002512-200522010-00002 · Cited by 142
Self-citationHepatitis C and interferon induced thyroiditis
Tomer, Y. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.11.008 · Cited by 119
Cytokines and HCV-Related Disorders
Fallahi, P., Ferri, C., Ferrari, S. M., Corrado, A., Sansonno, D. E., & Antonelli, A. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/468107 · Cited by 120
Thyroid Peroxidase as an Autoantigen
McLachlan, S. M., & Rapoport, B. (2007) · Thyroid · doi:10.1089/thy.2007.0169 · Cited by 115
Endocrine manifestations of hepatitis C virus infection
Antonelli, A., Ferri, C., Ferrari, S. M., Colaci, M., Sansonno, D. E., & Fallahi, P. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet1027 · Cited by 113
Interferon induced thyroiditis
Tomer, Y., & Menconi, F. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.07.004 · Cited by 112
The Role of BAFF System Molecules in Host Response to Pathogens
Sakai, J., & Akkoyunlu, M. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00046-17 · Cited by 109
Harii, N., Lewis, C. J., Vasko, V., McCall, K. D., Benavides-Peralta, U., Sun, X., Ringel, M. D., Saji, M., Giuliani, C., Napolitano, G., et al. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0100 · Cited by 107
Fabiani, S., Fallahi, P., Ferrari, S. M., Miccoli, M., & Antonelli, A. (2018) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-017-9440-1 · Cited by 98
Extrahepatic Manifestations of Hepatitis C Virus Infection
Zignego, A. L., & Craxı̀, A. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.03.012 · Cited by 90
Extrahepatic Manifestations and Autoantibodies in Patients with Hepatitis C Virus Infection
Himoto, T., & Masaki, T. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/871401 · Cited by 89
Thyroid dysfunctions secondary to cancer immunotherapy
Chalan, P., Dalmazi, G. D., Pani, F., Remigis, A. D., Corsello, A., & Caturegli, P. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0778-8 · Cited by 83
Thyroid Cancer in HCV-Related Chronic Hepatitis Patients: A Case-Control Study
Antonelli, A., Ferri, C., Fallahi, P., Pampana, A., Ferrari, S. M., Barani, L., Marchi, S., & Ferrannini, E. (2007) · Thyroid · doi:10.1089/thy.2006.0194 · Cited by 79
Muller, I., Moran, C., Lecumberri, B., Decallonne, B., Robertson, N., Jones, J., & Dayan, C. M. (2019) · European Thyroid Journal · doi:10.1159/000500881 · Cited by 78
“Thyroid dysfunction (TD) is a common side effect of many treatments acting with different mechanisms, including but not limited to interferon alpha [1], interleukin-2 [2], thalidomide [3], amiodarone [4], radiation therapy [5], lithium [6], bexarotene [7], immune check-point inhibitors [8], and…”
BackgroundAutoimmune manifestations in viral hepatitis
Vergani, D., & Mieli‐Vergani, G. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0328-6 · Cited by 75
Effects of Vitamin D treatment on thyroid autoimmunity
Şimşek, Y., Cakır, I., Yetmiş, M., Dizdar, O. S., Başpınar, O., & Gökay, F. (2016) · Journal of Research in Medical Sciences · doi:10.4103/1735-1995.192501 · Cited by 71
Investigating the shared genetic architecture between hypothyroidism and rheumatoid arthritis
Peng, Z., Huang, W., Tang, M., Chen, B., Yang, R., Liu, Q., Liu, C., & Long, P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1286491 · Cited by 72
Type 1 Diabetes and Interferon Therapy
Nakamura, K., Kawasaki, E., Imagawa, A., Awata, T., Ikegami, H., Uchigata, Y., Kobayashi, T., Shimada, A., Nakanishi, K., Makino, H., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2274 · Cited by 68
Antonelli, A., Ferrari, S. M., Fallahi, P., Ghiri, E., Crescioli, C., Romagnani, P., Vitti, P., Serio, M., & Ferrannini, E. (2010) · Cytokine · doi:10.1016/j.cyto.2010.01.009 · Cited by 68
Interferon induced Autoimmune Thyroid Disease (AITD): a model for human autoimmunity
Oppenheim, Y. L., Ban, Y., & Tomer, Y. (2004) · Autoimmunity Reviews · doi:10.1016/j.autrev.2004.03.003 · Cited by 68
Ferri, S., Muratori, L., Lenzi, M., Granito, A., Bianchi, F. B., & Vergani, D. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784746824 · Cited by 65
Baldazzi, V., Tassi, R., Lapini, A., Santomaggio, C., Carini, M., & Mazzanti, R. (2010) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2010.07.015 · Cited by 64
Caraccio, N., Giannini, R., Cuccato, S., Faviana, P., Berti, P., Galleri, D., Dardano, A., Basolo, F., Ferrannini, E., & Monzani, F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1173 · Cited by 63
Interferon Family Cytokines in Obesity and Insulin Sensitivity
Huang, L.-Y., Chiu, C.-J., Hsing, C., & Hsu, Y. (2022) · Cells · doi:10.3390/cells11244041 · Cited by 59
Environmental triggers of thyroiditis: Hepatitis C and interferon-α
Menconi, F., Hasham, A., & Tomer, Y. (2011) · Journal of Endocrinological Investigation · doi:10.1007/bf03346699 · Cited by 57
Interferon alpha and neuromuscular disorders
Stübgen, J. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.12.008 · Cited by 56
Kee, K., Lee, C., Wang, J., Tung, H., Changchien, C., Lu, S., & Wang, P. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.03947.x · Cited by 54
Indolfi, G., Stagi, S., Bartolini, E., Salti, R., de Martino, M., Azzari, C., & Resti, M. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03009.x · Cited by 54
Sunitinib (Sutent)-Induced Thyrotoxicosis Due to Destructive Thyroiditis: A Case Report
Faris, J. E., Moore, A. F., & Daniels, G. H. (2007) · Thyroid · doi:10.1089/thy.2007.0104 · Cited by 54
COVID-induced thyroid autoimmunity
Brancatella, A., Viola, N., Santini, F., & Latrofa, F. (2023) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2023.101742 · Cited by 48
Hepatitis C infection: a systemic disease with extrahepatic manifestations.
Ali, A. Y., & Zein, N. N. (2005) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.72.11.1005 · Cited by 48
Weetman, A. P. (2014) · Clinical Endocrinology · doi:10.1111/cen.12427 · Cited by 46
Thyroid dysfunction in patients with chronic hepatitis C: Virus‐ or therapy‐related?
Vezali, E., Elefsiniotis, I. S., Mihas, C. C., Konstantinou, E. A., & Saroglou, G. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05812.x · Cited by 45
Autoantibodies in chronic hepatitis C: A clinical perspective
Narciso-Schiavon, J. L. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i8.1074 · Cited by 44
Pastore, F. (2016) · World Journal of Hepatology · doi:10.4254/wjh.v8.i2.83 · Cited by 43
Do serum biomarkers really measure breast cancer?
Jesneck, J. L., Mukherjee, S., Yurkovetsky, Z. R., Clyde, M. A., Marks, J. R., Lokshin, A. E., & Lo, J. Y.-C. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-164 · Cited by 42
Side effects of medical therapy for chronic hepatitis C
Shiffman Mitchell, L. (2004) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32118-0 · Cited by 41
Thyroid dysfunction (TD) among chronic hepatitis C patients with mild and severe hepatic fibrosis
Rodriguez‐Torres, M., Ríos‐Bedoya, C. F., Ortiz‐Lasanta, G., Marxuach-Cuétara, A. M., & Jiménez‐Rivera, J. (2008) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31891-5 · Cited by 39
Thyroid disorders in patients with chronic hepatitis C using interferon-alpha and ribavirin therapy
Andrade, L. J. D. O., Atta, A. M., Atta, M. L. B. D. S., Mangabeira, C. N. K., & Paraná, R. (2011) · The Brazilian Journal of Infectious Diseases · doi:10.1016/s1413-8670(11)70208-2 · Cited by 37
Thyroid dysfunction in hepatitis C individuals treated with interferon-alpha and ribavirin: a review
Andrade, L. J. D. O., Atta, A. M., D'Almeida, A., & Paraná, R. (2008) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702008000200009 · Cited by 37
Poma, A. M., Basolo, A., Bonuccelli, D., Proietti, A., Macerola, E., Ugolini, C., Torregrossa, L., Alì, G., Giannini, R., Vignali, P., et al. (2021) · Thyroid · doi:10.1089/thy.2021.0345 · Cited by 37
Ruiz‐Riol, M., Armengol, M. P., Colobrán, R., Sánchez‐Pla, Á., Borràs, F. E., Lucas, A., Martínez-Cáceres, E. M., & Pujol‐Borrell, R. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.01.002 · Cited by 36
Mazziotti, G., Sorvillo, F., Piscopo, M., Morisco, F., Cioffi, M., Stornaiuolo, G., Gaeta, G. B., Molinari, A. M., Lazarus, J. H., Amato, G., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0093 · Cited by 35
Sorafenib Induced Thyroiditis in Two Patients with Hepatocellular Carcinoma
van Doorn, L., Eskens, F. A. L. M., Visser, T. J., van der Lugt, A., Mathijssen, R. H. J., & Peeters, R. P. (2011) · Thyroid · doi:10.1089/thy.2010.0234 · Cited by 34
Lévy-Bohbot, N., Young, J., Orgiazzi, J., Buffet, C., François, M., Bernard‐Chabert, B., Lukas-Croisier, C., & Delemer, B. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02104 · Cited by 34
Prevalence of HCV antibodies in autoimmune thyroid disease.
Testa, A. C., Castaldi, P. J., Fant, Gf, F., Grieco, De Rosa, A., Mg, P., & Rosa, G. D. (2006) · PubMed · Cited by 34
Satzger, I., Meier, A., Schenck, F., Kapp, A., Hauschild, A., & Gutzmer, R. (2007) · International Journal of Cancer · doi:10.1002/ijc.22951 · Cited by 33
Costelloe, S. J., Wassef, N., Schulz, J., Vaghjani, T., Morris, C. J., Whiting, S., Thomas, M., Dusheiko, G. M., Jacobs, M., & Vanderpump, M. P. J. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03785.x · Cited by 32
Opportunistic autoimmune disorders
Kong, Y. M., Wei, W., & Tomer, Y. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05138.x · Cited by 33
Determinants of thyroid autoantibody production in Hashimoto’s thyroiditis
Zaletel, K. (2007) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.3.2.217 · Cited by 33
Autoimmune and Neoplastic Thyroid Diseases Associated with Hepatitis C Chronic Infection
Fallahi, P., Ferrari, S. M., Politti, U., Giuggioli, D., Ferri, C., & Antonelli, A. (2014) · International Journal of Endocrinology · doi:10.1155/2014/935131 · Cited by 31
Tran, H. A., Attia, J., Levett-Jones, T. L., & Batey, R. G. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04771.x · Cited by 31
Panicker, S. P., Ganguly, T., Consolo, M. C., Price, V. H., Mirmirani, P., Honda, K. S., & Karnik, P. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038449 · Cited by 33
Friedrich-Rust, M., Theobald, J., Zeuzem, S., & Bojunga, J. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2008.01059.x · Cited by 30
Zhao, T., Zhang, Y., Wang, F., Zhang, B., Chen, Q., Liu, L., Yan, L., Yang, Y., Meng, Q., Huang, J., et al. (2023) · PubMed Central · doi:10.1007/s11032-022-01351-3 · Cited by 29
Kesavachandran, C. N., Haamann, F., & Nienhaus, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055364 · Cited by 29
Hepatitis C virus infection and risk of thyroid cancer: A systematic review and meta-analysis
Wang, P., Jing, Z., Liu, C., Xu, M., Wang, P., Wang, X., Yin, Y., Cui, Y., Ren, D., & Rao, X. (2017) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2017.01.003 · Cited by 28
Extrahepatic Manifestations of Hepatitis C Virus
Viganò, M., & Colombo, M. (2015) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2015.07.006 · Cited by 26
Thyroid dysfunction in patients with hepatitis C on IFN-α therapy
Antonelli, A., Ferri, C., & Fallahi, P. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.168 · Cited by 26
Tran, H. A., Reeves, G. E. M., & Jones, T. L. (2008) · QJM · doi:10.1093/qjmed/hcn150 · Cited by 25
Tran, H. A., Levett-Jones, T. L., & Batey, R. G. (2005) · BMC Endocrine Disorders · doi:10.1186/1472-6823-5-8 · Cited by 24
Yan, Z., Fan, K., Yi, F., Wang, X., Mao, Q., Deng, G., & Wang, Y. (2012) · Hepatitis Monthly · doi:10.5812/hepatmon.6390 · Cited by 23
Restless legs syndrome due to interferon‐α
LaRochelle, J. S., & Karp, B. I. (2004) · Movement Disorders · doi:10.1002/mds.20049 · Cited by 23
Antonelli, A., Ferrari, S. M., Mancusi, C., Mazzi, V., Pupilli, C., Centanni, M., Ferri, C., Ferrannini, E., & Fallahi, P. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.08.267 · Cited by 22
Is hepatitis C virus a risk factor for thyroid autoimmunity?
Floreani, A., Betterle, C., Carderi, I., Presotto, F., Pedini, B., Moscon, A., Andrea, O. D., & Chiaramonte, M. (2006) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00699.x · Cited by 22
Matsuse, D., Ochi, H., Tashiro, K., NOMURA, T., Murai, H., Taniwaki, T., & Kira, J. (2005) · Internal Medicine · doi:10.2169/internalmedicine.44.68 · Cited by 21
Masood, N., Ghori, R. A., Memon, A., Memon, S., Memon, K. I., Memon, I. A., Jaffri, M., & Baloch, G. H. (2008) · PubMed · Cited by 21
Nadeem, A., Aslam, M. N., Khan, D. A., Hussain, T., & Khan, S. (2009) · PubMed · Cited by 20
Yang, J., Kao, Y.-H., Dai, C., Huang, J., Hsieh, M., Lin, Z., Chen, S., Hsieh, M., Wang, L., Chuang, W., et al. (2010) · Hepatology International · doi:10.1007/s12072-010-9208-0 · Cited by 19
Kuang, M., Wang, S., Wu, M., Ning, G., Yao, Z., & Li, L. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.12.006 · Cited by 19
Drugs and Other Substances Interfering with Thyroid Function
Montanelli, L., Benvenga, S., Hegedüs, L., Vitti, P., Latrofa, F., & Duntas, L. H. (2018) · Endocrinology · doi:10.1007/978-3-319-45013-1_27 · Cited by 18
Adverse effects of high-dose interferon-α-2a treatment for chronic hepatitis B
Kartal, E. D., ALPAT, S. N., Özgüneş, İ., & Usluer, G. (2007) · Advances in Therapy · doi:10.1007/bf02877700 · Cited by 18
Andrade, L. J. D. O., D’Oliveira, A., Silva, C. A. C., Nunes, P., França, L. S., Malta, A. M. A., & Paraná, R. (2011) · PubMed · Cited by 17
Hwang, Y., Kim, W. K., Kwon, S. Y., Yu, H. M., Kim, J. H., & Choe, W. H. (2015) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2015.30.6.792 · Cited by 16
Endocrine and metabolic disorders in HTLV-1 infected patients
Alves, C., & Dourado, L. (2010) · The Brazilian Journal of Infectious Diseases · doi:10.1016/s1413-8670(10)70120-3 · Cited by 16
Munakata, K., Takashima, K., Nishiyama, M., Asano, N., Mase, A., Hioki, K., Ohnishi, Y., Yamamoto, M., & Watanabe, K. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-30 · Cited by 16
Amino acid sequence homologies between HCV polyprotein and thyroid antigens
Martocchia, A., & Falaschi, P. (2007) · Internal and Emergency Medicine · doi:10.1007/s11739-007-0018-x · Cited by 16
Watanabe, T., Hirono, H., Hasegawa, K., Soga, K., & Shibasaki, K. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.06890.x · Cited by 16
Bakács, T. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.08.005 · Cited by 15
Tran, H. A., Levett-Jones, T. L., Ianna, E. A., Foy, A., & Reeves, G. E. M. (2012) · Endocrine Practice · doi:10.4158/ep12195.ra · Cited by 16
Metadata
- Authors
- Prummel, M. F., & Laurberg, P.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Aalborg University Hospital (DK)
- Venue
- Thyroid
- Publisher
- SAGE Publications
- Published
- 2003-06
- Volume
- 13
- Issue
- 6
- Pages
- 547-551
- ISSN
- 1050-7256 (ISSN-L)
- 1557-9077
- OpenAlex
- W1805116264
- Cited by
- 221
- References
- 28
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 1 · 2023: 4 · 2022: 6 · 2021: 3 · 2020: 5 · 2019: 5 · 2018: 8 · 2017: 6 · 2016: 10 · 2015: 6 · 2014: 8 · 2013: 5 · 2012: 18
- FWCI
- 8.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Thyroid (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Keywords
- interferon-alpha, autoimmune thyroid disease, hepatitis C virus, drug-induced autoimmunity, thyroid peroxidase antibodies, primary hypothyroidism, Graves' disease, destructive thyroiditis, sex differences, genetic susceptibility
- MeSH terms
- Autoantibodies, Autoimmune Diseases, Hepatitis C, Humans, Risk Factors, Sex Factors, Thyroid Diseases, Viruses, Incidence, Interferon-alpha
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
